Diagnosis-Related Group Codes
Lymphoma and Leukemia with Major O.R. Procedures with MCC
846Chemotherapy without Acute Leukemia as Secondary Diagnosis with MCC
822Lymphoma and Leukemia with Major O.R. Procedures without CC/MCC
841Lymphoma and Non-Acute Leukemia with CC
847Chemotherapy without Acute Leukemia as Secondary Diagnosis with CC
821Lymphoma and Leukemia with Major O.R. Procedures with CC
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.